Under construction – not a live service
Sign in
Taking people in PolandNo phase

Compares two heart pacing methods after valve implantation in people with heart block

Compares two pacing methods to prevent heart failure in adults with heart block.

Plain-language title generated from the registry record
Registry title: Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI

Key facts

Where
Katowice, PolandSee the site

Where in Poland

  • Medical University of Silesia in KatowiceKatowice, PolandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of Silesia
Trial code
NCT05966675
Record updated
8 June 2025
Original description
The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).Read full original descriptionShow less

Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post Transcatheter Aortic Valve Implantation

The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).

Inclusion: transcatheter aortic valve implantation (TAVI) in up to 30 days before qualification to pacemaker implantation; Fulfilled criteria for permanent pacemaker implantation according do 2021 ESC guidelines; Written informed consent; Age of at least 18 years.

Exclusion: Permanent pacemaker implantation before TAVI procedure; The occurrence of conduction disturbances more than 30 days after TAVI procedure; No written informed consent; Inability to obtain informed consent from participant; Predicted inability to obtain cooperation from patient during observation period.

ClinicalTrials.gov NCT05966675